NeuroPace (NPCE) Gross Profit Growth (3y) (2023 - 2026)
NeuroPace (NPCE) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.95% |
| 10 | NeuroPace | 463.82 Mn | 412.12 Mn | 18.91 Mn | 16.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.45% |
| Mar 31, 2026 | 20.28% |
| Dec 31, 2025 | 32.72% |
| Sep 30, 2025 | 38.52% |
| Jun 30, 2025 | 34.42% |
| Mar 31, 2025 | 28.05% |
| Dec 31, 2024 | 26.09% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | 14.73% |
| Mar 31, 2024 | 16.25% |
| Dec 31, 2023 | 18.12% |
| Sep 30, 2023 | 8.51% |
| Jun 30, 2023 | 30.23% |
| Mar 31, 2023 | 13.70% |